These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 16316460)

  • 21. Methotrexate-induced liver cirrhosis in a patient of psoriasis.
    Avasthi G; Bhatt P; Singh J
    J Assoc Physicians India; 2012 May; 60():47-8. PubMed ID: 23029724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Have methotrexate-induced liver fibrosis and cirrhosis become rare? A matter for reappraisal of routine liver biopsies.
    Zachariae H
    Dermatology; 2005; 211(4):307-8. PubMed ID: 16286736
    [No Abstract]   [Full Text] [Related]  

  • 23. Etanercept therapy allows the tapering of methotrexate and sustained clinical responses in patients with moderate to severe psoriasis.
    Yamauchi PS; Lowe NJ
    Int J Dermatol; 2008 Feb; 47(2):202-4. PubMed ID: 18211500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of aseptic pleuropericarditis in a patient with chronic plaque psoriasis under methotrexate therapy.
    Savoia F; Gaddoni G; Casadio C; Patrizi A; Spadola G; Bassi P; Albertini F; Ballardini G; Briganti E; Casolari S; De Donà D; Menni B; Zanotti M; De Angelis P
    Dermatol Online J; 2010 Feb; 16(2):13. PubMed ID: 20178709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
    Thomas JA; Aithal GP
    Am J Clin Dermatol; 2005; 6(6):357-63. PubMed ID: 16343024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute methotrexate toxicity in psoriasis].
    Arévalo-López A
    Gac Med Mex; 1999; 135(5):513-6. PubMed ID: 10596492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Eventration and methotrexate in psoriasis].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2010 Oct; 137(10):672. PubMed ID: 20932456
    [No Abstract]   [Full Text] [Related]  

  • 28. Sequential liver biopsies during long-term methotrexate treatment for psoriasis: a reappraisal.
    Boffa MJ; Chalmers RJ; Haboubi NY; Shomaf M; Mitchell DM
    Br J Dermatol; 1995 Nov; 133(5):774-8. PubMed ID: 8555032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comment on: Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Boffa MJ; Smith A; Chalmers RJ
    Rheumatology (Oxford); 2009 Nov; 48(11):1464; author reply 1465. PubMed ID: 19671697
    [No Abstract]   [Full Text] [Related]  

  • 30. Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?
    Aithal GP; Haugk B; Das S; Card T; Burt AD; Record CO
    Aliment Pharmacol Ther; 2004 Feb; 19(4):391-9. PubMed ID: 14871278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of psoriasis by methotrexate in the era of biotherapies: a study in 21 Tunisian patients].
    Khaled A; Ben Hamida M; Zeglaoui F; Kharfi M; Ezzine N; Fazaa B
    Therapie; 2012; 67(1):49-52. PubMed ID: 22487502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The treatment of psoriasis vulgaris: 1% topical methotrexate gel.
    Eskicirak B; Zemheri E; Cerkezoglu A
    Int J Dermatol; 2006 Aug; 45(8):965-9. PubMed ID: 16911386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is methotrexate safe in the treatment of psoriatic patients?
    Al-Waiz MM; Jafar SJ
    Saudi Med J; 2004 Apr; 25(4):536-7. PubMed ID: 15083237
    [No Abstract]   [Full Text] [Related]  

  • 34. Folic acid supplementation and methotrexate therapy for psoriasis.
    Hughes R; Harries M; Chalmers RJ; Kirby B
    J Am Acad Dermatol; 2006 Aug; 55(2):366-7. PubMed ID: 16844540
    [No Abstract]   [Full Text] [Related]  

  • 35. Systemic methotrexate therapy for psoriasis: past, present and future.
    Dogra S; Mahajan R
    Clin Exp Dermatol; 2013 Aug; 38(6):573-88. PubMed ID: 23837932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.
    Berends MA; Snoek J; de Jong EM; Van Krieken JH; de Knegt RJ; van Oijen MG; van de Kerkhof PC; Drenth JP
    Liver Int; 2007 Jun; 27(5):639-45. PubMed ID: 17498249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythema gyratum repens-like eruption occuring in resolving psoriasis during methotrexate therapy.
    Singal A; Sonthalia S; Pandhi D
    Int J Dermatol; 2010 Mar; 49(3):306-7. PubMed ID: 20465670
    [No Abstract]   [Full Text] [Related]  

  • 38. Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases.
    Falize L; Guillygomarc'h A; Perrin M; Lainé F; Guyader D; Brissot P; Turlin B; Deugnier Y
    Hepatology; 2006 Aug; 44(2):472-7. PubMed ID: 16871557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome and female gender, but not methotrexate, are the important associations of significant liver fibrosis in patients with moderate-to-severe psoriasis as detected by transient elastography.
    Mahajan R; Dogra S; Handa S; Razmi TM; Narang T; Rathi S; Dhiman RK; Saikia B; Karim A
    Indian J Dermatol Venereol Leprol; 2020; 86(6):649-655. PubMed ID: 32643632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate and psoriasis: consensus conference.
    Kalb RE; Strober B; Weinstein G; Lebwohl M
    J Am Acad Dermatol; 2011 Jun; 64(6):1179. PubMed ID: 21571176
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.